Abstract
Coccidioidal meningitis (CM) is a lethal, chronic granulomatous disease of the leptomeninges caused by Coccidioides immitis. Untreated CM is uniformly fatal and accounts for the majority of the deaths caused by coccidioidomycosis.1,2,3 However, aggressive treatment with amphotericin B (AMB) reduces mortality and prolongs survival. This chapter will review our current concepts of CM, its diagnosis, and its treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
W. C. Buss, T. E. Gibson, and M. A. Gifford, Coccidioidomycosis of the meninges, Calif. Med. 72: 167–169 (1950).
R. W. Huntington, Jr., Morphology and racial distribution of fatal coccidioidomycosis, J. Am. Med. Assoc. 169: 115–118 (1959).
R. W. Huntington, W. J. Waldmann, J A Sargent, H. O’Connell, R. Wybel, and D. Croll, Pathologic and clinical observations of 142 cases of fatal coccidioidomycosis with necropsy, in: Coccidioidomycosis ( L. Ajello, ed.), University of Arizona Press, Tucson (1967), pp. 143–167.
R. G. Caudill, C. E. Smith, J. A. Reinarz, Coccidioidal meningitis: A diagnostic challenge, Am. J. Med. 49: 360–365 (1970).
D. Pappagianis and R. Crane, Survival in coccidioidal meningitis since introduction of amphotericin B, in: Coccidioidomycosis: Current Clinical and Diagnostic Status ( L. Ajello, ed.), Symposia Specialists, Miami (1977), pp. 223–237.
W. A. Winn, The use of amphotericin B in the treatment of coccidioidal disease, Am. J. Med. 27: 617–635 (1959).
E. C. Dickson and M. A. Gifford, Coccidioides infection (coccidioidomycosis). II. The primary type of infection, Arch. Intern. Med. 62: 853–871 (1938).
E. C. Dickson, Coccidioidomycosis, J. Am. Med. Assoc. 111: 1362–1365 (1938).
W. D. Forbus and A. M. Bestebreutje, Coccidioidomycosis: a study of 95 cases of the disseminated type with special reference to the pathogenesis of the disease, Mil. Surg. 99: 619–653 (1946).
K. H. Abbott and O. I. Cutler, Chronic coccidioidal meningitis, Arch. Pathol. 21: 320–330 (1936).
F. E. Jackson, D. Kent, and F. Clare, Quadriplegia caused by involvement of cervical spine with Coccidioides immitis, J. Neurosurg. 21: 512–515 (1964).
S. D. Ingham, Coccidioidal granuloma of the spine with compression of the spinal cord, Bull. Los Angeles Neurol. Soc. 1: 41–49 (1936).
C. W. Rand, Coccidioidal granuloma, Arch. Neurol. Psychiatry 23: 502–511 (1930).
M. L. Gottlieb, Coccidioidomycosis localized to the thoracic spinal cord and brain, with a plea for early diagnosis, Ariz. Med. 13: 131–139 (1956).
C. B. Courville and K. H. Abbott, Pathology of coccidioidal granuloma of the central nervous system and its envelopes, Bull. Los Angeles Neurol. Soc. 3: 27–41 (1938).
H. G. Schlumberger, A fatal case of cerebral coccidioidomycosis with cultural studies, Am. J. Med. Sci. 209: 483–496 (1945).
A. E. Rhoden, Coccidioidal brain abscess, Bull. Los Angeles Neurol. Soc. 11: 80–85 (1946).
D. M. Goldstein and J. B. McDonald, Primary pulmonary coccidioidomycosis, J. Am. Med. Assoc. 124: 557–561 (1944).
C. E. Smith, R. R. Beard, E. G. Whiting, and H. G. Rosenberger, Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases, Am. J. Public Health 36: 1394–1402 (1946).
C. E. Smith, M. T. Saito, R. R. Beard, R. M. Kepp, R. W. Clark, and B. U. Eddie, Serological tests in the diagnosis and prognosis of coccidioidomycosis, Am. J. Hyg. 52: 1–21 (1950).
P. C. Kelly, M. L. Sievers, R. Thompson, and C. Echols, Coccidioidal meningitis: results of treatment in 22 patients, in: Coccidioidomycosis, Current Clinical and Diagnostic Status ( L. Ajello, ed.), Symposia Specialists, Miami (1977), pp. 239–251.
E. Rosen and J. P. Belber, Coccidioidal meningitis of long duration, Ann. Intern. Med. 34: 796–809 (1951).
W. A. Winn, Coccidioidal meningitis: A follow-up report, in: Coccidioidomycosis ( L. Ajello, ed.), University of Arizona Press, Tucson (1967), pp. 55–62.
D. L. Reeves and C. F. Baisinger, Primary chronic coccidioidal meningitis: A diagnostic neurosurgical problem, J. Neurosurg. 2: 269–280 (1945).
S. C. Deresinski and D. A. Stevens, Coccidioidomycosis in compromised hosts, Medicine 54: 377–395 (1974).
N. Smithline, D. A. Ogden, A. I. Cohn, and K. Johnson, Disseminated coccidioidomycosis in renal transplant patients, in: Coccidioidomycosis: Current Clinical and Diagnostic Status ( L. Ajello, ed.), Symposia Specialists, Miami (1977), pp. 201–208.
V. S. Rowland, R. E. Westfall, and W. A. Hinchcliffe, Fatal coccidioidomycosis: analysis of host factors, in: Coccidioidomycosis: Current Clinical and Diagnostic Status ( L. Ajello, ed.), Symposia Specialists, Miami (1977), pp. 91–106.
H. Einstein, C. W. Holeman, Jr., L. Sandidge, and D. H. Holden, Coccidioidal meningitis, the use of amphotericin B in treatment, Calif. Med. 94: 339–343 (1961).
D. D. Norman and Z. R. Miller, Coccidioidomycosis of the central nervous system, a case of ten years’ duration, Neurology 4: 713–717 (1954).
C. F. Sweigert, H. W. Turner, and J. B. Gillespie, Clinical and roentgenologic aspects of coccidioidomycosis, Am. J. Med. Sci. 212: 652–673 (1946).
V. E. Jenkins and J. C. Postlewaite, Coccidioidal meningitis: report of four cases with necropsy findings in 3 cases, Ann. Intern. Med. 35: 1068–1084 (1951).
F. Unterharnscheidt, M. DeBeukelaer, and J. L. Simon, Chronic untreated coccidioidomycosis of the central nervous system: a case of 7 1/2 years duration, Tex. Rep. Biol. Med. 27: 513–524 (1969).
W. A. Winn, The treatment of coccidioidal meningitis. The use of amphotericin B in a group of twenty-five patients, Calif. Med. 101: 78–89 (1964).
S. C. Deresinski, J N Galgiani, and D. A. Stevens, Miconazole treatment of human coccidioidomycosis: status report, in: Coccidioidomycosis: Current Clinical and Diagnostic Status ( L. Ajello, ed.), Symposia Specialists, Miami (1977), pp. 267–294.
D. S. Zealear and W. A. Winn, The neurosurgical approach in the treatment of coccidioidal meningitis. Report of 10 cases, in: Coccidioidomycosis ( L. Ajello, ed.), University of Arizona Press, Tucson (1967), pp. 43–53.
D. Pappagianis, N. J. Lindsey, C. E. Smith, and M. T. Saito, Antibodies in human coccidioidomycosis: immunoelectrophoretic properties, Proc. Soc. Exp. Biol. Med. 118: 118–122 (1965).
Y. Sawaki, M. Huppert, J. W. Bailey, and Y. Yagi, Patterns of human antibody reactions in coccidioidomycosis, J. Bacteriol. 91: 422–427 (1966).
R. W. P. Cutler, G. V. Watters, J. P. Hammerstad, and E. Merler, Origin of cerebrospinal fluid gamma globulin in subacute sclerosing leukoencephalitis, Arch. Neurol. 17: 620–628 (1967).
S. Cohen and R. Bannister, Immunoglobulin synthesis within the central nervous system in disseminated sclerosis, Lancet 1: 366–367 (1967).
C. E. Smith, M. T. Saito, and S. A. Simons, Pattern of 39,500 serologic tests in coccidioidomycosis, J. Am. Med. Assoc. 160: 546–552 (1956).
D. Pappagianis, M. Saito, and K. H. Van Hoosear, Antibody in cerebrospinal fluid in non-meningitic coccidioidomycosis, Sabouraudia 10: 173–179 (1972).
E. A. Petersen, B. A. Friedman, E. D. Crowder, and D. Rifkind, Coccidioidouria: clinical significance, Ann. Intern. Med. 85: 34–38 (1976).
M. J. Fiese, Coccidioidomycosis, p. 152, Charles C. Thomas, Springfield, Ill. (1958).
J. J. Ellner and J. E. Bennett, Chronic meningitis, Medicine 55: 341–370 (1976).
W. A. Winn, Coccidioidomycosis, Med. Clin. North Am. 47: 1131–1148 (1963).
M. S. Collins and D. Pappagianis, Uniform susceptibility of various strains of Cocci dioides immitis to amphotericin B, Antimicrob. Agents Chemother. 11: 1049–1055 (1977).
D. D. Bindschadler and J. E. Bennett, A pharmacologic guide to the clinical use of amphotericin B, J. Infect. Dis. 120: 427–436 (1969).
C. W. Holeman and P. Johnson, Long term follow-up of amphotericin treated coccidioidal meningitis patients, Proceedings of the Twenty-First Annual Coccidioidomycosis Study Group, Abstract 1 (1976).
H. E. Einstein, Coccidioidomycosis of the central nervous system, in: Advances in Neurology, Vol. 6 ( R. A. Thompson and J. R. Green, eds.), Raven Press, New York (1974), pp. 101–106.
H. W. Buchsbaum, Clinical management of coccidioidal meningitis, in: Coccidioidomycosis: Current Clinical and Diagnostic Status ( L. Ajello, ed.), Symposia Specialists, Miami (1977), pp. 191–200.
J. J. Castellot, F. W. Pitts, and F. H. Mowrey, A case of coccidioidal meningitis arrested by prolonged therapy with amphotericin B., Antibiot. Med. Clin. Ther. 6: 480–485 (1959).
N. P. Alazraki, J. Fierer, S. E. Halpern, and R. W. Becker, Use of a hyperbaric solution for administration of intrathecal amphotericin B, N. Engl. J. Med. 290: 641–646 (1974).
K. P. Glynn, N. P. Alazraki, and T. A. Waltz, Coccidioidal meningitis-intrathecal treatment with hyperbaric Amphotericin B., Calif. Med. 119: 6–9 (1973).
M. LeClerc and S. T. Giammona, Coccidioidal meningitis, the use of amphotericin B intravenously and intrathecally by repeated lumbar punctures, West. J. Med. 122: 251–254 (1975).
J. P. Sung and J. G. Grendahl, Clinical experimental therapy with miconazole for human disseminated coccidioidomycosis, in: Coccidioidomycosis: Current Clinical and Diagnostic Status ( L. Ajello, ed.), Symposia Specialists, Miami (1977), pp. 293–310.
J. R. Keane, Cisternal puncture complications-treatment of coccidioidal meningitis with amphotericin B, Calif. Med. 119: 10–15 (1973).
A. Underman, Private communication of a paper delivered at the Third International Coccidioidomycosis Symposium, Tucson (1976).
D. L. Kelly, Lateral cervical puncture for myelography, J. Neurosurg. 29: 106–110 (1968).
R. A. Ratcheson and A. K. Ommaya, Experience with subcutaneous cerebrospinal-fluid reservoir, preliminary report of 60 cases, N. Engl. J. Med. 279: 1025–1031 (1968).
R. D. Diamond and J. E. Bennett, A subcutaneous reservoir for intrathecal therapy of fungal meningitis, N. Engl. J. Med. 288: 186–188 (1973).
A. J. Atkinson, Jr., and D. D. Bindschadler, Parmacokinetics of intrathecally administered amphotericin B, Am. Rev. Resp. Dis. 99: 917–924 (1969).
E. Goldstein, M. J. Winship, and D. Pappagianis, Ventricular fluid and the management of coccidioidal meningitis, Ann. Intern. Med. 77: 243–246 (1972).
J. P. Utz, J. E. Bennett, M. W. Brandriss, W. T. Butler, and G.J. Hill II, Amphotericin B toxicity, Ann. Intern. Med. 61: 334–354 (1964).
N. T. Carnevale, J. N. Galgiani, J. W. Langston, and D. A. Stevens, Myelopathy due to intrathecal amphotericin B, in: Coccidioidomycosis: Current Clinical and Diagnostic Status ( L. Ajello, ed.), Symposia Specialists, Miami (1977), pp. 259–260.
N. T. Carnevale, J. N. Galgiani, J. W. Langston, D. A. Stevens, and M. K. Herrick, Amphotericin-induced myelopathy, Neurology 27: 359 (1977).
H. B. Levine, D. A. Stevens, J. M. Cobb, and A. E. Gebhart, Miconazole in coccidioidomycosis. I. Assay of activity in mice andin vitro, J. Infect. Dis. 132: 407–414 (1975).
D. A. Stevens, H. B. Levine, and S. C. Deresinski, Miconazole in coccidioidomycosis. II. Therapeutic and pharmacologic studies in man, Am. J. Med. 60: 191–202 (1976).
S. C. Deresinski, R. B. Lilly, H. B. Levine, J. N. Galgiani, and D. A. Stevens, Treatment of fungal meningitis with miconazole, Arch. Intern. Med. 137: 1180–1185 (1977).
D. A. Stevens, Miconazole in the treatment of systemic fungal infections, Am. Rev. Resp. Dis. 116: 801–806 (1977).
S. H. Cheu and W. J. Waldmann, Unusual complications of ventriculo-atriostomy for communicating hydrocephalus in coccidioidal meningitis, in: Coccidioidomycosis ( L. Ajello, ed.), University of Arizona Press, Tucson (1967), pp. 25–30.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kelly, P.C. (1980). Coccidioidal Meningitis. In: Stevens, D.A. (eds) Coccidioidomycosis. Current Topics in Infectious Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1712-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1712-9_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1714-3
Online ISBN: 978-1-4757-1712-9
eBook Packages: Springer Book Archive